DEC 30, 2019

MedMira Reports First Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2019.

NOV 28, 2019

MedMira Reports 2019 Fourth Quarter and Year End Financial Results 

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for
the financial year ended July 31, 2019.

JUN 29, 2019

MedMira Reports Third Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2019

MAR 29, 2019

MedMira Reports Second Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial
results for the quarter ended January 31, 2019.

MAR 28, 2019

Medmira Reports 2018 Fourth Quarter and Year End Financial Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2018.

MAR 14, 2019

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

FEB 5, 2019

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

JAN 22, 2019

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

JAN 8, 2019

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

DEC 28, 2018

Medmira Reports First Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2018.

DEC 25, 2018

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

DEC 11, 2018

Management Cease Trade Order Update

MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued by the Nova Scotia Securities Commission on November 29, 2018.

NOV 27, 2018

MedMira Inc. Announces Appointment of Auditor and Late Filing of Annual Financial Statements

MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has engaged Arsenault Best Cameron Ellis of Charlottetown, Prince Edward Island, as auditor for the Company’s financial statements for the year ended July 31, 2018.

SEPT 6, 2018

MedMira Announces Revocation of Cease Trade Order

MedMira Inc. (MedMira) (TSXV: MIR), announced that the Nova Scotia Securities Commission has revoked the Cease Trade Order.

JUNE 29, 2018

MedMira Reports Third Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2018.

MARCH 29, 2018

MedMira Reports Second Quarter Results

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2018.

FEBRUARY 1, 2018

MedMira Announces AGM Results and Stock Option Grant

MedMira Inc. (MedMira) (TSXV: MIR) held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia.

DECEMBER 22, 2017

MedMira Reports First Quarter Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2017.

NOVEMBER 28, 2017

MedMira Reports 2017 Fourth Quarter and Year End Financial Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2017.

JUNE 29, 2017

MedMira Reports FY2017 Third Quarter Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ending April 30, 2017.

MAY 1, 2017

MedMira Receives CE Mark for Syphilis/HIV Multipex Rapid Test

MedMira Inc. (MedMira) (TSXV:MIR), has received CE Mark on its syphilis/HIV rapid test, Multiplo TP/HIV.

MARCH 31, 2017

MedMira Reports FY2017 Second Quarter Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and six month periods ending January 31, 2017.

JANUARY 30, 2017

MedMira Announces AGM Results and Stock Option Grant

MedMira Inc. (MedMira) (TSXV:MIR), held its Annual General Meeting of Shareholders on January 27, 2017.

DECEMBER 30, 2016

MedMira Reports 2017 First Quarter Financial Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three month period ending October 31, 2016.

NOVEMBER 28, 2016

MedMira Reports 2016 Fourth Quarter and Year End Financial Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2016.

JUNE 29, 2016

MedMira Reports FY2016 Third Quarter Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ending April 30, 2016.

MARCH 24, 2016

MedMira Reports Second Quarter Results for FY2016

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and six month periods ended January 31, 2016.

MARCH 3, 2016

MedMira Announces Departure of Board Director

MedMira Inc. (MedMira) (TSXV:MIR), announced today that Dr. Martial Lacroix is stepping down from his role on the Company’s Board of Directors effective immediately.

FEBRUARY 1, 2016

MedMira Announces AGM Results

MedMira Inc. (MedMira) (TSXV:MIR), held its 2016 Annual General and Special Meeting of Shareholders on January 29, 2016.

JANUARY 8, 2016

MedMira Directors Granted Stock Options

MedMira Inc. (MedMira) (TSXV:MIR), has granted the Company’s Board of Directors options to purchase common shares under its Stock Option Plan which was approved by shareholders at the Company’s Annual General and Special Meeting on January 25, 2013.

DECEMBER 14, 2015

MedMira Reports Fiscal First Quarter 2016 Financial Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three month period ending October 31, 2015.

DECEMBER 7, 2015

MedMira Debuts Reveal G4 Rapid HIV Test at National HIV Prevention Conference

New whole blood applications powered by MedMira Rapid Vertical Flow Technology revealed at Booth 109

NOVEMBER 24, 2015

MedMira Reports 2015 Fourth Quarter and Year End Financial Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter and year ended July 31, 2015.

October 19, 2015

MedMira Receives FDA Approval for the Reveal G4 Rapid HIV-1 Antibody Test

Expands proven Rapid Vertical Flow Technology platform to next generation whole blood rapid HIV test and new market sectors in the U.S.

SEPTEMBER 8, 2015

MedMira Closes Investment from OnSite Lab

MedMira Inc. (MedMira) (TSXV:MIR), has closed the CAD $5 million equity investment with OnSite Lab Holding AG (OnSite Lab) announced September 2, 2015.

SEPTEMBER 2, 2015

MedMira Targets Technology Promotion with Latest Investment from OnSite Lab

Company focuses on business development activities to capitalize on technology platform opportunities and adds industry expertise to support continued innovation

AUGUST 17, 2015

MedMira Board Reinforces Biotech Bench Strength with New Appointment

MedMira Inc. (MedMira) (TSXV:MIR), announced today that controlling shareholder, OnSite Lab Holding AG (OnSite Lab) has appointed Dr. Philippe Dro as its representative on the Company’s Board of Directors, effective as of August 7, 2015.

JULY 20, 2015

MedMira Opens US Subsidiary in Atlanta, GA

New office to support U.S.-focused product line expansion, growing customer base, and increasing sales initiatives such as upcoming 2015 AACC Annual Meeting

MAY 29, 2015

MedMira Reports Third Quarter Results

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the three and nine month periods ended April 30, 2015.

APRIL 20, 2015

MedMira Submits Reveal G4 Whole Blood Rapid HIV Test for U.S. FDA Approval

Company’s most advanced rapid HIV test expands product applications to point-of-care settings

APRIL 13, 2015

MedMira Directors Granted Stock Options

MedMira Inc. (TSXV:MIR) announced today that the Company’s Board of Directors and Corporate Secretary have been granted stock options to purchase common shares under its Stock Option Plan which was approved by shareholders at the Company’s Annual General and Special Meeting on January 25, 2013.

MARCH 27, 2015

MedMira Closes Equity Investment with OnSite Lab

MedMira Inc. (TSXV:MIR) has closed the CAD $1.1 million equity investment with OnSite Lab Holding AG (OnSite Lab).

MARCH 25, 2015

MedMira Expands U.S. Growth Plan with New Equity Investment from OnSite Lab

MedMira Inc. (TSXV:MIR) is entering into a new CAD $1.1 million equity investment with OnSite Lab Holding AG to support the Company’s growth plans in the United States.

MARCH 20, 2015

MedMira Reports Second Quarter Results

MedMira Inc. (TSXV:MIR), reported today on its financial results for the three and six month periods ended January 31, 2015.

FEBRUARY 5, 2015

MedMira Board of Directors Re-elected at Annual Shareholders Meeting

MedMira Inc. (TSXV:MIR), reported that the Company’s Board of Directors was re-elected at its 2015 Annual General Meeting of Shareholders.

JANUARY 28, 2015

Two of MedMira’s Multiplo Tests Procured for UNAIDS Program in Central Asia

Company’s multiplex rapid tests for HIV, syphilis, hepatitis B and C to be used in mobile clinics